研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

马兜铃酸-IIIa对小鼠的长期毒性评价。

Long-term toxicity evaluation of aristolochic acid-IIIa in mice.

发表日期:2024 May 24
作者: Lianmei Wang, Yuan Wang, Yong Zhao, Chunying Li, Yan Yi, Jingzhuo Tian, Guiqin Li, Zhong Xian, Fang Wang, Jing Meng, Yushi Zhang, Jiayin Han, Chen Pan, Suyan Liu, Meiting Liu, Chenyue Liu, Aihua Liang
来源: TOXICOLOGY

摘要:

马兜铃酸 (AA)-IIIa 是马兜铃科植物中存在的 AA 类似物。为了评价AA-IIIa的慢性毒性,给小鼠灌胃培养基对照,1mg/kg AA-IIIa和10mg/kg AA-IIIa,并指定为对照(CTL),AA-IIIa低剂量(AA-分别为Ⅲa-L)组和AA-IIIa高剂量组(AA-Ⅲa-H)组。 AA-IIIa 每周施用 3 次,每隔一天施用一次,持续 24 周(24 周时间点)。此后,一些小鼠立即处死,而另一些小鼠在AA-Ⅲa停药后29或50周(53或74周时间点)处死。收集血清和器官分别用于生化和病理分析。对 AA-IIIa 治疗小鼠的肾脏、肝脏和胃组织进行全基因组测序,以检测单核苷酸多态性 (SNP)。 AA-IIIa-H小鼠在66周时死亡,其余小鼠在69周时表现出垂死状态。 AA-IIIa 可诱导小鼠轻微肾小管损伤、成纤维细胞增生和前胃癌。 AA-IIIa 未对膀胱、肠、肝脏、心脏、脾脏、肺和睾丸组织造成病理改变。此外,AA-IIIa 增加了肾脏中的 C:G > A:T 突变;然而,与对照小鼠相比,24周时间点AA-IIIa-H小鼠的肝脏和前胃组织中没有观察到SNP突变变化。因此,我们怀疑AA-IIIa在过量和长期给药后对小鼠具有潜在的致突变性。另一方面,前胃是小鼠特有的器官,但在人类中并不存在;因此,我们推测AA-Ⅲa引起的胃毒性不适合作为人体毒理学评价的参考。我们建议对含有 AA-IIIa 的马兜铃科植物进行适当监管,避免过量和长期服用含有 AA-IIIa 的药物。版权所有 © 2024 Elsevier B.V. 保留所有权利。
Aristolochic acid (AA)-IIIa is an AA analog present in Aristolochiaceae plants. To evaluate the chronic toxicity of AA-IIIa, mice were intragastrically administered with media control, 1mg/kg AA-IIIa, and 10mg/kg AA-IIIa, and designated as the control (CTL), AA-IIIa low dose (AA-Ⅲa-L), and AA-IIIa high dose (AA-Ⅲa-H) groups, respectively. AA-IIIa was administered three times a week, every other day, for 24 weeks (24-week time point). Thereafter, some mice were sacrificed immediately, while others were sacrificed 29 or 50 weeks after AA-Ⅲa withdrawal (53- or 74-week time point). Serum and organs were collected for biochemical and pathological analyses, respectively. Whole-genome sequencing was performed on the kidney, liver, and stomach tissues of AA-IIIa-treated mice for single-nucleotide polymorphism (SNP) detection. AA-IIIa-H mice died at 66 weeks, and the remaining mice showed moribund conditions at the 69 weeks. AA-IIIa induced minor kidney tubule injury, fibroblast hyperplasia, and forestomach carcinoma in mice. Bladder, intestine, liver, heart, spleen, lung, and testis tissues were not pathologically altered by AA-IIIa. In addition, AA-IIIa increased the C:G > A:T mutation in the kidney; however, no SNP mutation changes were observed in the liver and forestomach tissues of AA-IIIa-H mice at the 24-week time point compared with control mice. Therefore, we suspect that AA-IIIa is potentially mutagenic for mice after overdose and long-term administration. On the other hand, the forestomach is a unique organ in mice, but it does not exist in humans; thus, we hypothesize that the stomach toxicity induced by AA-Ⅲa is not a suitable reference for toxicological evaluation in humans. We recommend that Aristolochiaceae plants containing AA-IIIa should be properly supervised, and overdosing and long-term administration of drugs containing AA-IIIa should be avoided.Copyright © 2024 Elsevier B.V. All rights reserved.